Financhill
Back

Castle Biosciences 10K Form

Sell
44

CSTL
Castle Biosciences

Last Price:
33.32
Seasonality Move:
29.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive CSTL News And Ratings

See the #1 stock for the next 7 days that we like better than CSTL

CSTL Financial Statistics

Sales & Book Value

Annual Sales: $219.79M
Cash Flow: $16.96M
Price / Cash Flow: 27.16
Annual Sales: $15.77
Price / Book: 2.12

Profitability

EPS (TTM): 0.21000
Net Income (TTM): $6.08M
Gross Margin: $174.81M
Return on Equity: 1.49%
Return on Assets: 1.29%

Castle Biosciences Earnings Forecast

Key Castle Biosciences Financial Ratios

  • The Gross Profit Margin over the past 7 years for CSTL is 79.53%.
  • The Selling, General & Administrative Expenses for CSTL have been equal to 81.97% of Gross Profit Margin.
  • The Research & Development expenses have been 24.40% of Revenue.
  • The Interest Expense is -0.02% of Operating Income.
  • The Net Earning history of CSTL is -26.15% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Castle Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: CSTL
CUSIP: 14843C
Website: castlebiosciences.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 7.78
Quick Ratio: 7.45

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CSTL Technical Analysis vs Fundamental Analysis

Sell
44
Castle Biosciences (CSTL) is a Sell

Is Castle Biosciences a Buy or a Sell?